Wilmington Savings Fund Society FSB Invests $688,000 in HCA Healthcare, Inc. (NYSE:HCA)

Wilmington Savings Fund Society FSB purchased a new stake in HCA Healthcare, Inc. (NYSE:HCA) during the third quarter, according to the company in its most recent disclosure with the SEC. The firm purchased 1,692 shares of the company’s stock, valued at approximately $688,000.

A number of other large investors have also recently made changes to their positions in the company. Nisa Investment Advisors LLC lifted its position in shares of HCA Healthcare by 8.8% during the 2nd quarter. Nisa Investment Advisors LLC now owns 67,886 shares of the company’s stock worth $21,810,000 after purchasing an additional 5,464 shares during the last quarter. First Horizon Advisors Inc. boosted its position in shares of HCA Healthcare by 6.0% during the 2nd quarter. First Horizon Advisors Inc. now owns 1,496 shares of the company’s stock worth $481,000 after acquiring an additional 85 shares in the last quarter. ZWJ Investment Counsel Inc. raised its position in shares of HCA Healthcare by 3.5% during the 2nd quarter. ZWJ Investment Counsel Inc. now owns 1,082 shares of the company’s stock worth $348,000 after acquiring an additional 37 shares in the last quarter. Neo Ivy Capital Management purchased a new position in HCA Healthcare in the second quarter valued at approximately $302,000. Finally, Commerzbank Aktiengesellschaft FI lifted its position in shares of HCA Healthcare by 3.9% during the 2nd quarter. Commerzbank Aktiengesellschaft FI now owns 1,225 shares of the company’s stock worth $394,000 after buying an additional 46 shares during the last quarter. 62.73% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

A number of equities research analysts recently weighed in on the stock. TD Cowen reduced their price target on shares of HCA Healthcare from $450.00 to $440.00 and set a “buy” rating for the company in a research report on Monday, October 28th. Wolfe Research upgraded HCA Healthcare to a “strong-buy” rating in a research note on Thursday, August 29th. Wells Fargo & Company downgraded HCA Healthcare from an “equal weight” rating to an “underweight” rating and decreased their price objective for the company from $400.00 to $320.00 in a report on Monday, November 25th. Morgan Stanley assumed coverage on shares of HCA Healthcare in a research note on Tuesday, September 3rd. They set an “equal weight” rating and a $427.00 price target for the company. Finally, Cantor Fitzgerald reiterated an “overweight” rating and set a $392.00 target price on shares of HCA Healthcare in a research note on Tuesday, October 1st. One analyst has rated the stock with a sell rating, four have given a hold rating, twelve have issued a buy rating and two have assigned a strong buy rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $387.13.

HCA Healthcare Stock Performance

NYSE:HCA opened at $313.93 on Monday. The stock has a market cap of $79.52 billion, a PE ratio of 14.10, a price-to-earnings-growth ratio of 1.21 and a beta of 1.63. HCA Healthcare, Inc. has a fifty-two week low of $263.22 and a fifty-two week high of $417.14. The firm’s fifty day simple moving average is $355.34 and its 200-day simple moving average is $358.75. The company has a quick ratio of 1.00, a current ratio of 1.12 and a debt-to-equity ratio of 48.71.

HCA Healthcare Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, December 27th. Investors of record on Friday, December 13th will be issued a $0.66 dividend. This represents a $2.64 dividend on an annualized basis and a dividend yield of 0.84%. The ex-dividend date is Friday, December 13th. HCA Healthcare’s dividend payout ratio is currently 11.85%.

Insiders Place Their Bets

In related news, SVP Phillip G. Billington sold 3,897 shares of HCA Healthcare stock in a transaction dated Thursday, November 14th. The stock was sold at an average price of $350.00, for a total transaction of $1,363,950.00. Following the completion of the sale, the senior vice president now owns 52,702 shares in the company, valued at approximately $18,445,700. This trade represents a 6.89 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, insider Erol R. Akdamar sold 2,900 shares of HCA Healthcare stock in a transaction dated Thursday, November 14th. The stock was sold at an average price of $353.00, for a total transaction of $1,023,700.00. Following the sale, the insider now owns 6,843 shares of the company’s stock, valued at approximately $2,415,579. This trade represents a 29.76 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.60% of the stock is owned by company insiders.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.